Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology
Disease Category: Bladder Disorders
Trial Information
Study for Overactive Bladder
One in six people struggles with a FREQUENT URGE TO URINATE. We're working to expand treatment options for the future. If you experience a frequent urge to urinate, difficulty preventing leakage or other problems with urinating, you may be able to participate in a clinical research study. We're conducting a clinical research study of an investigational drug designed to treat overactive bladder. If you participate, you will receive study-related care, monitoring, and study drug at no cost. To learn more, just call us.
Patient Inclusion Criteria:
- Male or Female patients 18 years or older
- Overactive Bladder for 3 months or longer
- Urinary frequency at least 8 times per day
- Urinary urgency at least one time per day
Patient Exclusion Criteria:
- Patients who are breast-feeding, pregnant, or planning to become pregnant
- Sexually active female patients of child-bearing potential not practicing a highly reliable method of birth control
- Stress-predominant incontinence
- Self-catheterization
- Urinary tract infection, interstitial cystitis, bladder stones
- Malignant disease of the pelvic organs or pelvic radiation
- Severe hypertension
- Clinical study within 30 days
Michele Pleasant, Patient Recruitment Specialist
West Coast Clinical Research
5525 Etiwanda Ave., Suite 202
Tarzana, CA 91356
Phone: 818-776-0820, Ext. 101
Fax: 818-776-1269
EMail: mpleasant@wccresearch.com
View Google Map
Research Center Information: West Coast Clinical Research
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.